The environment that gave rise to historic levels of capital investment in healthcare has changed dramatically causing a retrenching in the number of deals taking place across the industry, OliveryWyman reports.
Record-low interest rates and high valuations over the past couple of years set the stage for private equity to pump billions of dollars into healthcare. But now inflation, fears of a recession, rising interest rates, record high valuation multiples, and the lingering impact of COVID-19 hang over the economy. Nonetheless, the shifting landscape creates opportunities for investors and healthcare firms alike to be more strategic in how they partner and access capital. Read more.
